tag:blogger.com,1999:blog-8550428.post116160241489414602..comments2024-03-28T13:38:36.788-04:00Comments on Pharma Marketing Blog: CGC: Old Wine in New BottlesVladhttp://www.blogger.com/profile/04114063498108633047noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-8550428.post-1161698671587236412006-10-24T10:04:00.000-04:002006-10-24T10:04:00.000-04:00John: Thank you for highlighting what many of us h...John: Thank you for highlighting what many of us have been thinking for a while now: why is everyone calling consumer-generated content "new?" How about patient communities like MSWatch.com that have been around for years and years, and feature thousands of patient stories, patient-generated tips, discussion board posts, etc. Patients benefit from this interaction, and pharmas benefit from patients' exposure to their messages, and their loyalty. The real challenge is for pharmas to quit hiding behind regulatory hurdles and figure out how to do consumer generated content on a broader scope, taking advantage of all of today's technologies.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-8550428.post-1161611903151643792006-10-23T09:58:00.000-04:002006-10-23T09:58:00.000-04:00John: Nice post. What I'd say is "new" about CGM ...John: <BR/><BR/>Nice post. What I'd say is "new" about CGM that goes beyond soliciting input from your stakeholders is the ability of established companies to engage in two-way dialogues with people around issues that are important to them. The key word in social media is the word "social." It's about engaging in meaningful conversations about important issues. And, you are correct, playing in this arena will require a great deal of transparency.Anonymousnoreply@blogger.com